Critical success factors for the fuzzy front end of innovation in the medical device industry

EMJ - Engineering Management Journal

Volumn 20, Issue 3, 2008, Pages 36-43

  Russell, Richard K ^a   Tippett, Donald D ^b  

^a MICROSOFT   (United States)

^b UNIVERSITY OF ALABAMA IN HUNTSVILLE   (United States)

Author keywords

Critical success factors; Process improvement; Project selection; Technology management

Indexed keywords

BIOMEDICAL EQUIPMENT; DIAGNOSIS; PRODUCT DEVELOPMENT; PROJECT MANAGEMENT;

BUSINESS EXECUTIVES; CRITICAL SUCCESS FACTOR; FUZZY FRONT END OF INNOVATIONS; IDEA SCREENING; MEDICAL DEVICE INDUSTRY; MEDICAL DEVICE MANUFACTURERS; PROCESS IMPROVEMENT; PROJECT SELECTION; SUCCESS FACTORS; TECHNOLOGY MANAGEMENTS;

MANAGERS;

EID: 54449087272     PISSN: 10429247     EISSN: None     Source Type: Journal    
DOI: 10.1080/10429247.2008.11431775     Document Type: Article

References (23)

1. Baker, B.N., D.C. Murphy, and D. Fisher, “Factors Affecting Project Success,” Project Management Handbook, Van Nostrand Reinhold (1983).
2. Bart, Christopher, “Product Innovation Charters: Mission Statements for New Products,” R&D Management, 32 (2002), pp. 23-34.
3. Brewerton, Paul, and Lynne Millward, Organizational Research Methods, SAGE Publications Ltd. (2001).
4. Bullen, Christine V., John F. Rockart, “A Primer on Critical Success Factors” Sloan School of Management (1981).
5. Caralli, Richard, The Critical Success Factor Method, Carnegie-Mellon SEI (2004).
6. Cooper, Robert G, Scott J. Edgett, and Elko J. Klienschmidt, “Portfolio Management: Fundamental to New Product Success” in The PDA ToolBook for NPD, Wiley (2002).
7. Crawford, C. Merle, “Defining the Charter for Product Innovation,” Sloan Management Review (Fall 1980).
8. Dryrhaug, Qinli, “A Generalized Critical Success Factor Process Model for Managing Offshore Development Projects in Norway,” NTNU (2002).
9. ECRI, “Universal Medical Device Nomenclature System” http://www.ecri.org/Products _and_Services/Products/UMDNS/ (2006)
10. FDA, “Improving Innovation in Medical Technology: Beyond 2002” http://www.fda.gov/bbs/topics/news/2003/beyond2002/ report.html
11. Frost and Sullivan, “Medical Devices Industry,” http://www.frost.com/prod/servlet/vp-further-info.pag?mode=open&sid= 2850206 (2005)
12. Gladwell, Malcolm, Blink: The Power of Thinking Without Thinking, Little Brown & Co. (2005).
13. Griffin, A., “Metrics for Measuring Product Development Cycle Time,” Journal of Product Innovation Management, 10 (1993), pp. 112-125.
14. Griffin, A., Drivers of NPD Success: The 1997 PDMA Report, PDMA (1997).
15. Griffin, A.L.P.A., “PDMA Success Measurement Project,” Journal of Product Innovation Management, 13 (1996), pp. 478-496.
16. Lawshe, C.H., “A Quantitative Approach to Content Validity” in Content Validity II, Bowling Green State University (1975).
17. McGrath, Michael E., Setting the PACE in Product Development, A Guide to Product and Cycle-time Excellence, Elsevier (1996).
18. Rockart, John F., “Chief Executives Define Their Own Data Needs,” Harvard Business Review (March-April 1979), pp. 81-93.
19. Seamon, Erika B., “Achieving Growth Through an Innovative Culture,” The PDMA ToolBox 2 for New Product Development, Wiley (2004).
20. Slevin, D., and Pinto, J., “The Project Implementation Profile,” Project Management Journal, (Sept. 1983), pp.57-70.
21. Shulman, R. S., “Study Suggests that Companies Know the Value of NPD,” PDMA’s Visions (2004).
22. Stevens, Greg, James Burley, “Dow Chemical Achieves Major Transformation of PO&E R&D Group,” Visions Magazine (July 2003).
23. Wheelwright, Steven C., and Kim B. Clark, Revolutionizing Product Development, The Free Press (1992).